Current Funding for Scientific Research

VCU Medical Center logoFunding for VCU:

5/05 - $50,000 - Evan R. Reiter, M.D.Assessment of smell and taste impairment in patients undergoing treatment for head & neck cancer

8/08 - $16,000 - Kelley Dodson, M.D.Antimicrobial prophylaxis for fractures of the maxillary sinus

1/10 - $44,864 - Arti Pandya, M.D.Early Detection and Intervention of Congenital Cytomegalovirus Associated Hearing Loss

8/08 - $37,300 - Chris Leffler, M.D.Intraocular pressure response to Timolol with Beta 1 and Beta 2 receptors

1/10 - $16,570 - Amiee Potter, Ph.D.Molecular research in calvarial suture morphogenesis

1/10 - $46,396 - Laurence DiNardo, M.D. & Catherine Dumur, Ph.D.Gene expression profiling for predicting the therapeutic effectiveness of chemoradiotherapy treatment in head and neck squamous cell carcinomas


Uva health system logoFunding for UVA:

9/08 - $24,690 - Bradley Kesser, M.D.Surgical repair of unilateral congenital aural atresia

1/10 - $22,671 - Spencer Payne, M.D.Effects of itraconazole on the development and differentiation of T helper cells

1/10 - $47,834 – Paul Yates, M.D.Use of human adipose-derived stem cells for treatment of diabetic retinopathy


EVMS logo Funding for EVMS:

5/08 - $49,500 - Sandeep Samudre, PhD., MPHAnti angiogenic effects of topically applied endocannabinoid analogs in a mouse mode of age related macular degeneration

5/09 - $10,000 - Michael Chu, M.D.Minimally invasive, Local Pharmacologic Ischemic Preconditioning with a Vasoconstrictor in a Rat Model: Non-surgical Vascular Delay.

5/09 - $44,280 - Joseph Han, M.D.Immune Response in Chronic Rhinosinusitis

5/10 - $49,870 - Alireza Hosseini, M.D.-inhibiting Vasoproliferation in a Rat Model of Retinopathy of Prematurity with a Novel Topical Anti-Tubulin Drug.


Other Funding:

5/08 - $49,958 - Wael Jarjour, M.D.Regulatory t cells role in the pathogenesis of human Sjorgren's syndrome (Ohio State University)

1/10 - $19,105 - Bradley T. Smith, M.D.Bevacizumab with and without laser for the treatment of central retinal vein occlusion.